Evogene Ltd. (EVGN)
Market Cap | 9.21M |
Revenue (ttm) | 9.45M |
Net Income (ttm) | -19.87M |
Shares Out | 5.37M |
EPS (ttm) | -3.95 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 98,188 |
Open | 1.710 |
Previous Close | 1.725 |
Day's Range | 1.560 - 1.711 |
52-Week Range | 1.560 - 10.400 |
Beta | 1.08 |
Analysts | Strong Buy |
Price Target | 12.00 (+627.27%) |
Earnings Date | Nov 21, 2024 |
About EVGN
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Huma... [Read more]
Financial Performance
In 2023, Evogene's revenue was $5.64 million, an increase of 236.72% compared to the previous year's $1.68 million. Losses were -$23.88 million, -10.36% less than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for EVGN stock is "Strong Buy" and the 12-month stock price forecast is $12.0.
News
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
LAV321demonstrated strong results in its third consecutive year of field trials in Europe REHOVOT, Israel , Nov. 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and subsidiar...
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials
Lavie Bio intends to commence Yalos® sales for soybean in 2025 US spring season REHOVOT, Israel , Nov. 12, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of E...
Evogene Schedules Third Quarter 2024 Financial Results Release
Zoom conference call scheduled for November 21, 2024, 9:00 AM ET REHOVOT, Israel , Nov. 7, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company target...
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
The collaboration has the power to foster breakthroughs in small molecule innovation for life science-based products REHOVOT, Israel , Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: ...
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya
The shipment, comprising over 100 tons, was delivered to company's customer in Africa REHOVOT, Israel , Oct. 29, 2024 /PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation so...
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
Following a successful first year, Israel Innovation Authority (IIA) approved financing second year of collaboration HAZEVA and REHOVOT, Israel , Oct. 8, 2024 /PRNewswire/ -- Watershed AC ("Watershed"...
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
The technology aims to reduce application costs, extend shelf life, and prolong bacterial viability after field application REHOVOT, Israel , Sept. 30, 2024 /PRNewswire/ -- Lavie Bio Ltd.
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
REHOVOT, Israel , Aug. 23, 2024 /PRNewswire/ -- Evogene Ltd. ("Evogene" or the "Company") (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based...
Evogene Ltd. (EVGN) Q2 2024 Earnings Call Transcript
Evogene Ltd. (NASDAQ:EVGN) Q2 2024 Earnings Conference Call August 22, 2024 9:00 AM ET Company Participants Ofer Haviv - President and CEO Yaron Eldad - CFO Yoash Zohar - CEO, Casterra Dan Jacob Gelv...
Evogene Reports Second Quarter 2024 Financial Results
Conference call and webcast: today, August 22 , 2024, 9:00 am ET Financial and Business Highlights: H1 2024 revenues $5.1M, up from $1.3M in H1 2023; Q2 2024 revenues $914K, up from $654K in Q2 2023. ...
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
REHOVOT, Israel , Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company targeting to revolutionize life-science pro...
Evogene Schedules Second Quarter 2024 Financial Results Release
Zoom conference call scheduled for 9:00 AM ET REHOVOT, Israel , Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutioni...
Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil
Castor seeds from Brazil will be ready for shipment during third quarter of 2024. Castor harvest season in Africa started as planned.
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
Following the reverse share split, the Company will have approximately 5,079,000 Ordinary Shares issued andoutstanding REHOVOT, Israel , July 23, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE...
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and REHOVOT, Israel , July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leadin...
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat
Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season REHOVOT, Israel , July 2, 2024 /PRNewswire/ -- Lavie Bio Ltd., a lead...
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country
Current castor seed production is expected to support the supply of the new order in 2024, valued at ~ $440K REHOVOT, Israel , June 25, 2024 /PRNewswire/ -- Casterra Ag Ltd ., a subsidiary of Evogene...
Evogene Ltd. (EVGN) Q1 2024 Earnings Call Transcript
Evogene Ltd. (NASDAQ:EVGN) Q1 2024 Earnings Conference Call May 23, 2024 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Yoash...
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO...
Evogene Reports First Quarter 2024 Financial Results
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating continued growth in 2024.
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds
These agreements are expected to support the production of approximately 500 tons of additional seeds, enabling the completion of standing orders by the end of 2024 and positioning Casterra to fulfill...
Evogene Schedules First Quarter 2024 Financial Results Release
Zoom conference call scheduled for 9:00 AM ET REHOVOT, Israel , May 9, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize...
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Preliminary data from Biomica's Phase 1 study of BMC128 will be showcased at the conference REHOVOT, Israel , April 16, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company de...
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
REHOVOT, Israel , April 11, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
Finally Foods is financed by the Israeli Innovation Authority (IIA) and The Kitchen Hub, and will be granted a license to utilize Evogene's AI technology REHOVOT, Israel , April 2, 2024 /PRNewswire/ -...